Available Programs

Today’s Concepts in EGFR TKIs for NSCLC

Join us for this interactive symposium on leveraging EGFR TKIs for optimal care of patients with EGFR-mutated NSCLC. You will gain insights from pharmacy and oncology experts Val R. Adams, PharmD, FCCP, BCOP; Matthew Gubens, MD, MS; and Philip Schwieterman, PharmD, MHA, on the latest first-line and second-line clinical data and how these new practice-changing data can be safely and effectively integrated into care plans for patients.

Unable to join us in San Diego? Register now for the live Webcast!

No additional fee is required to attend this CPE and/or CME/CNE activity; however, registration to AMCP Annual Meeting 2019 is required. 

2 upcoming events, beginning 03/26/2019More Information

Advances in Biomarker-Guided Cancer Immunotherapy

Join us for this CME-certified “Evening With Experts”! Interact with a panel of experts as they discuss their perspectives on the role of biomarkers when using immune checkpoint inhibition in cancer therapy and strategies for adopting these biomarkers in your practice.

The experts will address live and remote audience questions, challenges, and cases sent to them during the event.

Sign up now! Registration is complimentary.

This symposium is sponsored by Clinical Care Options, LLC and supported by grants from Bristol-Myers Squibb and Foundation Medicine. This is not an official program of the American Association for Cancer Research Annual Meeting.

2 upcoming events, beginning 03/30/2019More Information

Immunotherapy Combinations for Lung Cancers: Challenges and Opportunities of Evolving Treatments

Join us for this dynamic, CME-certified symposium! Led by an expert panel, this event will explore the evolving role of immune checkpoint inhibitors in lung cancer, including first-line combinations for SCLC and NSCLC, clinical pearls for optimal application of immune checkpoint combinations, a look forward at evolving checkpoint inhibitors, and case discussions of where checkpoint inhibitors fit into the standard of care setting.

Sign up now! Registration is complimentary.

This symposium is sponsored by Clinical Care Options, LLC and supported by a grant from Genentech. This is not an official program of the American Association for Cancer Research Annual Meeting.

2 upcoming events, beginning 03/30/2019More Information

Exploring New Treatment Strategies for Immune Checkpoint Blockade in Melanoma

Attend this live symposium in Atlanta to learn how experts are applying novel strategies in treating melanoma! Interact with the experts as they discuss best practices and emerging clinical data in an engaging, case-based format.

This symposium is sponsored by Clinical Care Options, LLC and supported by a grant from Merck & Co., Inc. This is not an official program of the American Association for Cancer Research Annual Meeting.

2 upcoming events, beginning 03/31/2019More Information

Today’s Concepts in EGFR TKIs for NSCLC

Join us for this interactive symposium on leveraging EGFR TKIs for optimal care of patients with EGFR-mutated NSCLC. You will gain insights from pharmacy and oncology experts Val R. Adams, PharmD, FCCP, BCOP; Matthew Gubens, MD, MS; and Philip Schwieterman, PharmD, MHA, on the latest first-line and second-line clinical data and how these new practice-changing data can be safely and effectively integrated into care plans for patients.

Unable to join us in Fort Worth? Register now for the live Webcast!

An official independent commercially supported symposium held in conjunction with the Hematology/Oncology Pharmacy Association’s 15th Annual Conference.

2 upcoming events, beginning 04/03/2019More Information

A Walk in the PARP: Therapeutic Strategies Targeting DNA Repair Defects in Prostate Cancer

Join us for this dynamic, CME-certified symposium where an expert panel led by Charles J. Ryan, MD, will review the evolving role of PARP inhibitors in prostate cancer, including an overview of DNA repair deficiencies in prostate cancer, guidance on genetic testing, an update on the latest clinical data on PARP inhibitors for the treatment of prostate cancer and future directions, and case discussions of where PARP inhibitors fit into the standard of care setting.

Sign up now! Registration is complimentary.

1 upcoming events, beginning 05/04/2019More Information

An Evening With Experts: Selecting and Sequencing Therapy in HR+/HER2- Metastatic Breast Cancer

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.

1 upcoming events, beginning 05/31/2019More Information

Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC

Interact with the experts during this dynamic CME/CE/CPE-certified 2-hour live satellite symposium at ASCO 2019! Expert faculty will provide their insights as they discuss and debate the optimal care of patients with EGFR-mutated non-small-cell lung cancer based on the latest available evidence.

Register today!

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.

1 upcoming events, beginning 05/31/2019More Information

B-Cell Malignancies—Expert Guidance on BTK Inhibitors for Today’s Clinic

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.

2 upcoming events, beginning 06/01/2019More Information

PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application and Genetic Testing

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.

1 upcoming events, beginning 06/01/2019More Information

Collaborative Strategies to Ensure Optimal Application of the Latest Treatment Approaches in HCC

Not an official event of the 2019 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer.

1 upcoming events, beginning 06/02/2019More Information

Integrating the Latest Therapeutic Advances to Optimize the Care of Veterans With Multiple Myeloma

Gain expert guidance on the latest treatment of multiple myeloma in this 1-hour interactive meeting. Afterward, an associated downloadable slideset and PDF resource will be available on the CCO Web site to enhance the information presented at the live meetings.

3 upcoming events, beginning 03/28/2019More Information

Optimal Use of BTK Inhibitors in B-Cell Malignancies: Perspectives for the Healthcare Team

Interact with peers while gaining expert insight on the optimal treatment of B-cell malignancies with BTK inhibitors in this interactive, case-based 1-hour live meeting, highlighting the latest clinical data as well as expert treatment options from CCO’s online treatment decision tool. After the meeting, download the associated slideset for use in your clinic.

2 upcoming events, beginning 04/04/2019More Information

Advanced Soft Tissue Sarcomas: Incorporating the Latest Advances Into Collaborative Care

Interact with an expert during this 1-hour, CME/CE/CPE-certified, live meeting examining recent advances and current best practices in managing patients with soft tissue sarcomas. This will include discussions of current recommendations and strategies to support physician collaboration and timely patient referral.

1 upcoming events, beginning 04/17/2019More Information

Understanding the Latest Therapeutic Advances in Multiple Myeloma

Join us for a live CME/CE-certified event to hear from experts on the latest data and therapeutic options for patients with myeloma.

1 upcoming events, beginning 04/25/2019More Information

Expert Perspectives on Therapeutic Advances to Improve Clinical Outcomes of Veterans With NSCLC

Acquire expert insight on the optimal care for your VHA patients with NSCLC in this complimentary, interactive 1-hour live meeting.

1 upcoming events, beginning 04/30/2019More Information

Advances in Pancreatic Cancer: Guidance to Improve the Care of Veterans

Interact with peers while gaining expert insight on optimal treatment of pancreatic cancer in this interactive 1-hour live meeting, and then download a summary resource guide and associated slideset for use in your clinic.

There are no upcoming events, please check back soon.

Current Therapeutic Approaches for Early-Stage HER2-Positive Breast Cancer

In this series of 1-hour CME-certified live meetings, expert faculty provide guidance on the latest evidence-based approaches for treating early-stage HER2-positive breast cancer. Afterward, use CCO’s online decision-support tool for early breast cancer and download the associated slideset to enhance the information presented at the live meeting.

There are no upcoming events, please check back soon.

Expert Treatment Recommendations on New Clinical Developments in Frontline Follicular Lymphoma

In this series of 1-hour CME-certified live meetings, expert faculty provide guidance on the latest evidence-based approaches for treating newly diagnosed follicular lymphoma. Afterward, use CCO’s online decision support tool for frontline follicular lymphoma and download the associated slideset and Clinical Resources to enhance the information presented at the live meeting.

There are no upcoming events, please check back soon.

Navigating the Evolving Treatment Landscape in Pancreatic Cancer: Expert Guidance for Clinicians

Gain expert guidance on the latest treatment of newly diagnosed and relapsed/refractory advanced pancreatic cancer in this 1-hour interactive meeting. Afterward, an associated downloadable slideset will be available on the CCO Web site to enhance the information presented at the live meetings.

There are no upcoming events, please check back soon.

New Adjuvant Treatment Strategies for Early-Stage HER2-Positive Breast Cancer

Register now for this complimentary, live 1-hour CE-certified meeting where you can gain expert guidance on the optimal nursing care of patients with HER2-positive early breast cancer. Afterward, utilize CCO’s online early breast cancer decision support tool (coming soon), view a CE-certified Webcast, and download the associated slideset and pocket guides to enhance the information presented at the live meetings.

There are no upcoming events, please check back soon.

New Treatments and Insights in MM: Equipping Nurses to Manage a Complex and Rapidly Evolving Disease

Interact with peers while gaining expert insight on optimal treatment of multiple myeloma in this interactive 1-hour live meeting, and then download a summary resource guide and associated slideset for use in your clinic.

There are no upcoming events, please check back soon.

Practical Guidance on Immune Checkpoint Inhibitors in NSCLC: CCO ClinicalImpact Live

Register now for this complimentary, live 1-hour CME/CE/CPE-certified meeting where you can gain expert guidance on the optimal application of immune checkpoint inhibitors in treating non-small-cell lung cancer and interact with faculty. Afterward, use CCO’s online NSCLC decision support tools and download the associated slideset and NSCLC Clinical Resource to enhance the information presented at the live meetings.

There are no upcoming events, please check back soon.